Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04962698 · ClinicalTrials.gov registry record · NA
Robotically Augmented Mental Practice
A NA study of Stroke, sponsored by Georgia Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT04962698: Completed NA study of Stroke, sponsored by Georgia Institute of Technology.
NCT04962698 is a NA study of Stroke that has completed, run by Georgia Institute of Technology. The registered enrollment target is 25 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04962698, a NA study of Stroke, has completed, sponsored by Georgia Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will develop and test a new paradigm of motor imagery for facilitating neuromotor excitability and performance of distal muscles in the upper limb by adopting a robotic prosthesis and integrating proven procedures for neuromotor facilitation. The scientific purpose of the study is to understand the effect of controlling a detached robotic prosthesis with proximal muscle activation on brain excitability of the resting arm muscles as well as reaction time. The efficacy of this task will be understood by comparing with other task conditions (motor imagery only, 2D visual feedback on a monitor, etc.) that do not involve the robotic prosthesis. The test of the developed system will be performed in healthy able-bodied adults. The feasibility of the system will be examined in post-stroke adults.
Primary Outcome
Peak-to-peak amplitude of motor evoked potential (MEP) of the hand muscle
Conditions Studied
Interventions
- BEHAVIORAL Visual motor imagery (MI)
- BEHAVIORAL Kinesthetic MI
- BEHAVIORAL Robotic-Hand Interaction with MI
- BEHAVIORAL Robotic-Hand Interaction without MI
- BEHAVIORAL Virtual-Hand Interaction
Study Locations (1)
Georgia
- Human Neuromuscular Physiology Lab - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-05-11 |
| Est. Completion | 2023-05-16 |
| Phase | NA |
What the finished NCT04962698 record still lists
NCT04962698 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 5 interventions - of which Visual motor imagery (MI) is the first listed.
NCT04962698 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT04962698 about?
NCT04962698 is a clinical study titled "Robotically Augmented Mental Practice". This project will develop and test a new paradigm of motor imagery for facilitating neuromotor excitability and performance of distal muscles in the upper limb by adopting a robotic prosthesis and integrating proven procedures for neuromotor facilitation. The scientific purpose of the study is to un...
What is the current status of trial NCT04962698?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-05-11. Estimated completion is 2023-05-16.
What conditions does trial NCT04962698 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT04962698?
The interventions under investigation include: Visual motor imagery (MI) (BEHAVIORAL), Kinesthetic MI (BEHAVIORAL), Robotic-Hand Interaction with MI (BEHAVIORAL), Robotic-Hand Interaction without MI (BEHAVIORAL), Virtual-Hand Interaction (BEHAVIORAL).
Who is sponsoring clinical trial NCT04962698?
This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04962698 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04962698's enrollment target sits among peer trials
25 327th of 454 higher than 120 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI